Globus Medical (GMED) PT Raised to $115 at Roth/MKM
Tweet Send to a Friend
Roth/MKM analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $115.00 (from $100.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
